Covered recipient · General Payments record
ROGER STUPP
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$113,144.48
- Reported across 43 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $60,270.00 | 4 |
| Travel and Lodging | $14,277.29 | 4 |
| Food and Beverage | $1,003.29 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novocure Inc. | $62,422.50 | 8 |
| Telix Pharmaceuticals | $5,422.87 | 2 |
| Ipsen Biopharmaceuticals, Inc | $4,567.50 | 1 |
| Alexion Pharmaceuticals, Inc. | $2,438.88 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $538.02 | 2 |
| Novocure GmbH | $160.81 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $98.88 | 05/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202932656 | CMS |
| Alexion Pharmaceuticals, Inc. | $2,340.00 | 06/09/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1202967444 | CMS |
| Boston Scientific Corporation | $443.87 | 05/07/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1181315446 | CMS |
| Boston Scientific Corporation | $94.15 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181315444 | CMS |
| Ipsen Biopharmaceuticals, Inc | $4,567.50 | 03/07/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1208841449 | CMS |
| Novocure GmbH | $115.81 | 06/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251145883 | CMS |
| Novocure GmbH | $45.00 | 10/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251145893 | CMS |
| Novocure Inc. | $225.76 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251153148 | CMS |
| Novocure Inc. | $6,856.42 | 01/15/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1251155529 | CMS |
| Novocure Inc. | $48,000.00 | 01/30/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1251154317 | CMS |
| Novocure Inc. | $169.82 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251152036 | CMS |
| Novocure Inc. | $100.00 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251152038 | CMS |
| Novocure Inc. | $1,052.74 | 10/28/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1251152040 | CMS |
| Novocure Inc. | $93.50 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1251148271 | CMS |
| Novocure Inc. | $5,924.26 | 12/17/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1251147080 | CMS |
| Telix Pharmaceuticals | $60.37 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189638443 | CMS |
| Telix Pharmaceuticals | $5,362.50 | 12/18/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1189638445 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.